
📝 This Images in Neurology report describes #TersonSyndrome after digital subtraction myelography, with substantial hemorrhage resolution and improved visual acuity after conservative management. ja.ma/4CbktIi

JAMA Neurology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

📝 This Images in Neurology report describes #TersonSyndrome after digital subtraction myelography, with substantial hemorrhage resolution and improved visual acuity after conservative management. ja.ma/4CbktIi

📝 Editorial: Higher exhaled #CarbonMonoxide levels among individuals who never smoked were associated with lower risk of #ParkinsonDisease, offering a potential clue to Parkinson disease etiology. ja.ma/4k43W2s

📊 Geographic access to infrastructure for subcutaneous anti-amyloid #AlzheimersDisease therapy was worse in rural communities and in areas with higher proportions of older adults, indicating that injectable treatment does not remove major access barriers. ja.ma/4Aq9o4v

Today, JAMA published Toward a Healthier Future Through Obesity Prevention and Care: The #JAMASummit Report on Obesity. 🔗 Read the full report: ja.ma/3WOKa1j #ObesityWeek #OW2026

📈 Among cognitively unimpaired adults, higher plasma #pTau217 and older age were associated with higher 5-year and 10-year risk of mild cognitive impairment and dementia, supporting individualized prognosis in preclinical #AlzheimersDisease. ja.ma/48RPMKP

Join JAMA and JAMA Network Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and leading experts in #obesity research, treatment, and policy for an inside look at Toward a Healthier Future: The #JAMASummit Report on Obesity. ➡️ Register now: ja.ma/4C8mRzy

📝 Viewpoint: #AdministrativeBloat has become a defining feature of #Neurology and academic medicine. This burden is associated with clinician burnout, reduced satisfaction, and less time for patient care and research. ja.ma/4zFcl1j

Presented at #CTAD26 from @JAMA_current: A plasma immunoassay for eMTBR-tau identified advanced insoluble tau pathology in #AlzheimerDisease across autopsy and tau #PET cohorts. ja.ma/4iUuItj @CTADconference

📝 Editorial: Evidence linking #AgentOrange and #ParkinsonDisease provides clarity for exposed veterans and highlights a public health concern, as a major component of the defoliant is still used on farms, golf courses, and around homes. ja.ma/4ful0LL

📈 Among US veterans, #AgentOrange exposure was associated with higher risk of #ParkinsonDisease, rapid eye movement sleep behavior disorder, and dementia with Lewy bodies, with stronger associations among those with more direct exposure. ja.ma/4zlnKCn

💬 Viewpoint: The role of #LeftAtrialAppendageClosure in #AtrialFibrillation may depend on patient phenotype, and more evidence is needed in patients who cannot take long-term direct oral anticoagulants. ja.ma/4zOwiCE

📢 Applications are open for the 2027 @JAMANeuro Editorial Fellowship. The 1-year fellowship begins February 1, 2027, and offers hands-on training in editorial processes and policies. 📅 Apply by December 15, 2026: ja.ma/4BQXaUg

📊🧠 A harmonized #TauPET visual reading framework for #AlzheimerDisease with five classes showed high agreement across raters and tracers, and identified more early-stage tau pathology than the regulatory-approved binary approach. ja.ma/4zEgW3S

Presented at #JCDP2026 from @JAMA_current: Plasma eMTBR-tau243 increased with advancing #CTE stage and showed strong discrimination for stage III and IV disease vs cognitively unimpaired controls, but not for stage I disease. ja.ma/4exFjHV

Among patients with relapsing #MultipleSclerosis, earlier and continuous ocrelizumab treatment was associated with better long-term relapse and disability control than delayed initiation after interferon beta-1a. ja.ma/4zw7kHD

📝 #JAMAReview: #AcuteIschemicStroke requires rapid brain imaging and urgent evaluation for reperfusion therapy. Learn more in this Review from @JAMA_current: ja.ma/4BZzooW